Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight
New York, USA, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight
The neurodegenerative disease market is witnessing steady growth, driven by the rising prevalence of disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Huntington's disease, particularly among the aging global population. Advances in disease-modifying therapies, biomarker-based diagnostics, and precision medicine are reshaping the treatment landscape and improving early intervention strategies. Increasing investments in neuroscience research, expanding clinical pipelines, and favorable regulatory support for innovative therapies are further accelerating market expansion. Additionally, growing awareness, improved healthcare infrastructure, and enhanced access to advanced treatments across emerging markets are expected to sustain the market's growth trajectory over the coming years.
DelveInsight’s Neurodegenerative Disease Market Insights report provides the current and forecast market analysis, individual leading neurodegenerative disease companies’ market shares, challenges, neurodegenerative disease market drivers, barriers, trends, and key neurodegenerative disease companies in the market.
Neurodegenerative Disease Market Summary
To read more about the latest highlights related to the neurodegenerative disease market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/neurodegenerative-disease-market
Key Factors Contributing to the Rise in Growth of the Neurodegenerative Disease Market
Get a sneak peek at the neurodegenerative disease market dynamics @ Neurodegenerative Disease Market Trends
Regional Neurodegenerative Disease Market Insights
North America
Europe
Asia-Pacific
To know more about why North America is leading the market growth in the neurodegenerative disease market, get a snapshot of the Neurodegenerative Disease Market Share
Recent Developmental Activities in the Neurodegenerative Disease Market
What is Neurodegenerative Disease?
Neurodegenerative diseases are a group of progressive disorders characterized by the gradual degeneration and loss of neurons in the brain, spinal cord, or peripheral nervous system, leading to a decline in cognitive, motor, sensory, or autonomic functions. These conditions typically worsen over time because damaged nerve cells have a limited ability to regenerate. Common neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, and multiple sclerosis, although the underlying mechanisms vary among disorders. Key pathological processes often involve abnormal protein aggregation, mitochondrial dysfunction, oxidative stress, neuroinflammation, and impaired cellular waste clearance. As global populations age, the prevalence of neurodegenerative diseases continues to rise, creating a significant healthcare and socioeconomic burden while driving extensive research into disease-modifying therapies, early diagnostic biomarkers, and innovative treatment approaches.
Neurodegenerative Disease Market Assessment
Which MedTech key players in the neurodegenerative disease market are set to emerge as the trendsetter explore @ Neurodegenerative Disease Market Analysis
Table of Contents
Interested in knowing the neurodegenerative disease market share by 2034? Click to get a snapshot of the Neurodegenerative Disease Market Size
Related Reports
Alzheimer's Disease Market
Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Alzheimer's disease companies, including Novo Nordisk, Eli Lilly, Suven Life Sciences, Bristol Myers Squibb, IGC Pharma, T3D Therapeutics, Lexeo Therapeutics, Axsome Therapeutics, Araclon Biotech S.L., Eisai, TauRx Therapeutics, GemVax & KAEL, AC Immune SA, Johnson & Johnson, Longeveron, Vaccinex, Sinaptica Therapeutics, and others.
Psychosis in Parkinson’s and Alzheimer’s Disease Market
Psychosis in Parkinson’s and Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psychosis in Parkinson’s and Alzheimer’s disease companies, including Sunovion Pharmaceuticals, Karuna Therapeutics, Vanda Pharmaceuticals, Suven Life Sciences, Enterin, Intra-Cellular Therapies, Merck Sharp & Dohme, and others.
Parkinson’s Disease Market
Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Parkinson’s disease companies, including UCB Biopharma SRL, Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma (NeuroDerm), AbbVie, Cerevel Therapeutics, LLC, and others.
Amyotrophic Lateral Sclerosis Market
Amyotrophic Lateral Sclerosis Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key ALS companies, including Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, Alector, GSK, NeuroSense Therapeutics, Biogen, Ionis Pharmaceuticals, Brainstorm Cell Therapeutics, Cytokinetics, Astellas Pharma, Apellis Pharmaceuticals, Clene Nanomedicine Biosciences, AL-S Pharma, MediciNova, Seelos Theraputics, Prilenia Therapeutics, AB Science, Eledon Pharmaceuticals, Revalesio Corporation, Biohaven Pharmaceuticals, UCB Pharma, Ra Pharmaceuticals, AI Therapeutics, and others.
Multiple Sclerosis Market
Multiple Sclerosis Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key multiple sclerosis companies, including Novartis, Sanofi, AB Science, Roche, Clene Nanomedicine, InnoCare Pharma, and others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.